Ibrutinib A tyrosine kinase inhibitor

The drug Ibrutinib is a Bruton’s tyrosine kinase (BTK) inhibitor. Healthcare professionals recommend this drug to treat patients with mantle cell lymphoma, chronic lymphocytic leukemia, chronic lymphocytic leukemia (CLL) with 17p deletion, and Waldenström’s macroglobulinemia. The active ingredient in the medicine is Ibrutinib, and the inactive ingredients are croscarmellose sodium, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate. It is available in the strength of 140 mg in the form of capsules. Ibrutinib 140 mg is readily available in India with multiple suppliers of generic drugs. To know more or to buy this medicine, dial 18008891064.


Who Upvoted this Story


Comments